Otonomy, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.otonomy.com
OTO-313 in Subjects With Unilateral Subjective Tinnitus
- First Posted Date
- 2021-04-02
- Last Posted Date
- 2023-01-06
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 153
- Registration Number
- NCT04829214
- Locations
- 🇺🇸
ChicagoENT, Chicago, Illinois, United States
🇵🇱Centrum Medyczne ZDROWA, Kraków, Poland
🇺🇸Dartmouth-Hitchcock Medical Center/Mary Hitchcock Memorial Hospital, Lebanon, New Hampshire, United States
OTO-413 in Subjects With Speech-in-Noise Hearing Impairment
- First Posted Date
- 2019-10-17
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 110
- Registration Number
- NCT04129775
- Locations
- 🇺🇸
South Florida ENT Associates or Research Centers of America, Miami, Florida, United States
🇺🇸JBR Clinical Research, Salt Lake City, Utah, United States
🇺🇸Research Centers of America, Hollywood, Florida, United States
OTO-313 in Subjects With Subjective Tinnitus
- First Posted Date
- 2019-04-17
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT03918109
- Locations
- 🇺🇸
WVU Medicine, Morgantown, West Virginia, United States
🇺🇸Silverstein Institute/Ear Research Foundation, Sarasota, Florida, United States
🇺🇸California Head & Neck Specialists, San Diego, California, United States
Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2022-12-07
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 148
- Registration Number
- NCT03664674
- Locations
- 🇧🇪
CHU de Liège - Ear-Nose-Throat Department, Liège, Belgium
🇵🇱Centrum Medyczne PROMED, Kraków, Poland
🇧🇪UZ Gent - Ear-Nose-Throat Department, Gent, Belgium
Study of OTO-104 in Subjects at Risk From Cisplatin-Induced Hearing Loss
- First Posted Date
- 2016-12-19
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT02997189
- Locations
- 🇺🇸
Contact Otonomy call center for trial locations, San Diego, California, United States
Phase 3 Study of OTO-201 in Acute Otitis Externa
- Conditions
- Acute Otitis ExternaSwimmer's Ear
- Interventions
- Drug: Sham Control
- First Posted Date
- 2016-06-15
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 262
- Registration Number
- NCT02801370
- Locations
- 🇨🇦
Call Otonomy call center for trial locations, Saskatoon, Canada
A 6-Month Extension Study of OTO-104 in Meniere's Disease
- First Posted Date
- 2016-05-11
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 142
- Registration Number
- NCT02768662
- Locations
- 🇺🇸
Many sites in Europe. Refer to the contact info listed below., San Diego, California, United States
Open Label Study of OTO-104 in Subjects With Meniere's Disease
- First Posted Date
- 2016-04-15
- Last Posted Date
- 2017-09-15
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT02740387
- Locations
- 🇨🇦
Call Otonomy call center for trial locations, London, Ontario, Canada
Dose Ranging Study of OTO-201 in AOMT
- Conditions
- Acute Otitis MediaAOMT
- Interventions
- First Posted Date
- 2016-03-25
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 95
- Registration Number
- NCT02719158
- Locations
- 🇺🇸
Contact Otonomy call center for trial locations, San Diego, California, United States
Study of OTO-104 in Subjects With Unilateral Meniere's Disease
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2023-01-13
- Lead Sponsor
- Otonomy, Inc.
- Target Recruit Count
- 176
- Registration Number
- NCT02717442
- Locations
- 🇺🇸
Many sites in Europe. Refer to the contact info listed below., San Diego, California, United States